SEC Form 3 · accession 0001209191-17-025176
Cascadian Therapeutics, Inc. · CASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Azelby
Director
Period of report
Mar 31, 2017
Accepted (ET)
Apr 4, 2017 · 5:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412067
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| No securities were benefically held | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.